Dew, I think you meant to say CRP instead of CGRP. The latter is the peptide strongly implicated in dural vasodilation related to migraine attacks. I will venture to say that Servier does not want them to publicly state the precise value?
Curiously, XOMA still hasn’t said what the cutoff value is between high CGRP and low CGRP for the two EOA trials.
I believe that when they first announced the new trial they said that the cutoff on the original trial was 2. But I don't believe it was in my notes - so it is subject to memory errors.